We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ITC Imposes 21-Month U.S. Ban on Botox Competitor, a Reduction From Initial Ban of 10 Years
ITC Imposes 21-Month U.S. Ban on Botox Competitor, a Reduction From Initial Ban of 10 Years
The import, sale and marketing of a competitor to AbbVie’s Botox wrinkle treatment must be stopped for nearly two years, the U.S. International Trade Commission (ITC) ruled this week.
